| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HLA complex group 18 | 0.722 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||||||
|
HLA complex group 17 | 0.769 | 0.346 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||||||
|
ring finger protein 39 | 0.760 | 0.538 | 2.0E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2009 | ||||||||
|
zinc ribbon domain containing 1 antisense, pseudogene | 0.691 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2009 | 2009 | |||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2009 | 2009 | ||||||||
|
negative elongation factor complex member E | 0.686 | 0.500 | 6.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
NBPF member 13, pseudogene | 0.890 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||||||
|
transcription factor 19 | 0.674 | 0.692 | 9.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2009 | 2009 | ||||||||
|
long intergenic non-protein coding RNA 2477 | 1.000 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||||
|
tripartite motif containing 31 | 0.626 | 0.577 | 4.3E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
tripartite motif containing 10 | 0.821 | 0.269 | 3.7E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
zinc ribbon domain containing 1 | 0.653 | 0.654 | 0.21 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
neurobeachin | 0.760 | 0.538 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
major histocompatibility complex, class II, DO beta | 0.705 | 0.500 | 1.9E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 6 | 2009 | 2009 | ||||||||
|
solute carrier family 35 member F4 | 0.931 | 0.038 | 8.6E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
DISC1 fusion partner 1 | 0.931 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||||||
|
glutamate metabotropic receptor 5 | 0.525 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2009 | ||||||||
|
tripartite motif containing 26 | 0.705 | 0.577 | 0.18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
psoriasis susceptibility 1 candidate 3 | 0.769 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2010 | 2010 | |||||||||
|
proline rich coiled-coil 2A | 0.656 | 0.654 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2010 | 2010 | ||||||||
|
abhydrolase domain containing 16A | 0.861 | 0.269 | 0.47 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
mucin 21, cell surface associated | 0.743 | 0.346 | 8.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
USP8 pseudogene 1 | 0.805 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 6 | 2010 | 2010 | |||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 |